Correlation Between MIRA Pharmaceuticals, and NetEase

Can any of the company-specific risk be diversified away by investing in both MIRA Pharmaceuticals, and NetEase at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MIRA Pharmaceuticals, and NetEase into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MIRA Pharmaceuticals, Common and NetEase, you can compare the effects of market volatilities on MIRA Pharmaceuticals, and NetEase and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MIRA Pharmaceuticals, with a short position of NetEase. Check out your portfolio center. Please also check ongoing floating volatility patterns of MIRA Pharmaceuticals, and NetEase.

Diversification Opportunities for MIRA Pharmaceuticals, and NetEase

-0.37

Correlation Coefficient

MIRA Pharmaceuticals,  NetEase

Very good diversification

The 3 months correlation between MIRA and NetEase is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding MIRA Pharmaceuticals, Common and NetEase in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NetEase and MIRA Pharmaceuticals, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MIRA Pharmaceuticals, Common are associated (or correlated) with NetEase. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NetEase has no effect on the direction of MIRA Pharmaceuticals, i.e., MIRA Pharmaceuticals, and NetEase go up and down completely randomly.

Pair Corralation between MIRA Pharmaceuticals, and NetEase

Given the investment horizon of 90 days MIRA Pharmaceuticals, is expected to generate 19.8 times less return on investment than NetEase. In addition to that, MIRA Pharmaceuticals, is 2.2 times more volatile than NetEase. It trades about 0.0 of its total potential returns per unit of risk. NetEase is currently generating about 0.12 per unit of volatility. If you would invest  7,639  in NetEase on September 14, 2024 and sell it today you would earn a total of  1,882  from holding NetEase or generate 24.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

MIRA Pharmaceuticals, Common  vs.  NetEase

MIRA Pharmaceuticals,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MIRA Pharmaceuticals, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, MIRA Pharmaceuticals, is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

NetEase

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in NetEase are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak technical and fundamental indicators, NetEase unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with MIRA Pharmaceuticals, and NetEase

The main advantage of trading using opposite MIRA Pharmaceuticals, and NetEase positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MIRA Pharmaceuticals, position performs unexpectedly, NetEase can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NetEase will offset losses from the drop in NetEase's long position.

The idea behind MIRA Pharmaceuticals, Common and NetEase pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.